MedTrace Logo

Study Evaluating the Effects of Toradol and Lyrica for Pain Control After Donor Nephrectomy

NCT03669081 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2019-08-15

Study results available
· View outcomes & findings →

Summary

The investigators will assess how the use of toradol and pregabalin affects return to bowel function and see if there is a difference in length of hospital stay. Narcotic use can affect bowel function so the investigators hypothesize that use of Toradol will decrease delayed bowel function and aid in a patients discharge and reduction of hospital stay.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Ketorolac

Ketorolac was administered intravenously: 30 mg in the operating room, and 15 mg every 6 hours for 7 doses post-operatively.

DRUG

Pregabalin

Pregabalin was administered orally: 75 mg 30 minutes prior to operation.

DRUG

Placebo oral capsule

Placebo oral capsule was administered orally 30 minutes prior to operation.

DRUG

Saline

Saline was administered intravenously: once in the operating room, and every 6 hours for 7 doses post-operatively.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-20
Primary Completion
2018-09-30
Completion
2018-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03669081 on ClinicalTrials.gov